Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule for colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3, as well as symptomatic TGCT; Vanflyta, a FLT3 inhibitor...
Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 3 6225 1111
Address:
Daiichi Sankyo Building A/B, 3-5-1, Nihonbashi-honcho, Chuo, Japan
